Brain access of monoclonal antibodies as imaged and quantified by 89Zr-antibody PET: Perspectives for treatment of brain diseases

Sophie E. M. Veldhuijzen van Zanten; Philip C. de Witt Hamer; Guus A. M. S. van Dongen

doi:10.2967/jnumed.118.220939

Brain access of monoclonal antibodies as imaged and quantified by 89Zr-antibody PET: Perspectives for treatment of brain diseases

Sophie E. M. Veldhuijzen van Zanten
, Philip C. de Witt Hamer
, Guus A. M. S. van Dongen

Department of Pediatrics, Amsterdam, Netherlands
Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands
Department of Neurosurgery, Amsterdam, Netherlands
Department of Radiology and Nuclear Medicine, 1007 MB Amsterdam, Netherlands

Research output: Contribution to journal › Review article › Academic › peer-review

17 Downloads (Pure)

Original language	English
Pages (from-to)	615-616
Journal	Journal of nuclear medicine
Volume	60
Issue number	5
DOIs	https://doi.org/10.2967/jnumed.118.220939
Publication status	Published - 1 May 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.2967/jnumed.118.220939

Brain-access-of-monoclonal-antibodies-as-imaged-and-quantified-by-89zr-antibody-pet-perspectives-for-treatment-of-brain.pdfFinal published version, 430 KBLicence: Taverne

Cite this

@article{0d5f24d267c743199e55ba602a638e2f,

title = "Brain access of monoclonal antibodies as imaged and quantified by 89Zr-antibody PET: Perspectives for treatment of brain diseases",

author = "\{Veldhuijzen van Zanten\}, \{Sophie E. M.\} and \{de Witt Hamer\}, \{Philip C.\} and \{van Dongen\}, \{Guus A. M. S.\}",

year = "2019",

month = may,

day = "1",

doi = "10.2967/jnumed.118.220939",

language = "English",

volume = "60",

pages = "615--616",

journal = "Journal of nuclear medicine",

issn = "0161-5505",

publisher = "Society of Nuclear Medicine Inc.",

number = "5",

}

Brain access of monoclonal antibodies as imaged and quantified by 89Zr-antibody PET: Perspectives for treatment of brain diseases. / Veldhuijzen van Zanten, Sophie E. M.; de Witt Hamer, Philip C.; van Dongen, Guus A. M. S.
In: Journal of nuclear medicine, Vol. 60, No. 5, 01.05.2019, p. 615-616.

Research output: Contribution to journal › Review article › Academic › peer-review

TY - JOUR

T1 - Brain access of monoclonal antibodies as imaged and quantified by 89Zr-antibody PET: Perspectives for treatment of brain diseases

AU - Veldhuijzen van Zanten, Sophie E. M.

AU - de Witt Hamer, Philip C.

AU - van Dongen, Guus A. M. S.

PY - 2019/5/1

Y1 - 2019/5/1

UR - https://www.scopus.com/pages/publications/85065517861

UR - https://www.ncbi.nlm.nih.gov/pubmed/30737301

U2 - 10.2967/jnumed.118.220939

DO - 10.2967/jnumed.118.220939

M3 - Review article

C2 - 30737301

SN - 0161-5505

VL - 60

SP - 615

EP - 616

JO - Journal of nuclear medicine

JF - Journal of nuclear medicine

IS - 5

ER -

Brain access of monoclonal antibodies as imaged and quantified by 89Zr-antibody PET: Perspectives for treatment of brain diseases

UN SDGs

Access to Document

Other files and links

Cite this